Ardea Biosciences, Inc. (RDEA) Misses Q1 Views
Ardea Biosciences, Inc. (Nasdaq: RDEA) reported Q1 EPS of ($0.59), $0.09 worse than the analyst estimate of ($0.50). Revenue for the quarter came in at $1.77 million versus the consensus estimate of $3.86 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guess? (GES) Tops Q2 EPS by 7c; Guides Higher
- Nimble Storage (NMBL) Tops Q2 EPS by 1c, Sales Beat; Guides In-Line
- J. M. Smucker (SJM) Tops Q1 EPS by 12c; Maintains Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!